The Amyloid Precursor Protein Is Developmentally Regulated and Correlated with Synaptogenesis
Abstract
Metabolism of the amyloid precursor protein (APP) may contribute to the molecular changes observed in Alzheimer's disease, but the function of the protein in the non-pathologic nervous system remains unknown. In vitro studies have suggested that APP can participate in cellular adhesion and may thus contribute to neuronal differentiation in cultured cells. Here we show, in the primary visual pathway of the hamster, that APPs are developmentally regulated proteins rapidly transported to the growing tips of nerve fibers. Transmembrane forms of higher molecular weight (120 and 140 kDa) are preferentially associated with the rapid elongation of axons. Interestingly, another full-length form of 110 kDa and a soluble form of 100 kDa which lacks the C-terminal domain increase at the time of end-arbor formation and synaptogenesis and then decline when mature connections are established, suggesting that target recognition and synaptic contact may result in a signal for APP cleavage in the CNS in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
APP is developmentally regulated with maximal expression during synaptogenesis and subsequently declines when mature connections are completed.
“APP is developmentally regulated with maximal expression during synaptogenesis and subsequently declines when mature connections are completed [48,49].”
From FMRP Mediates mGluR5-Dependent Translation of Amyloid Precursor Protein (2007) · cites this paper as [49]
Cited by
Sorted by citations
FMRP Mediates mGluR5-Dependent Translation of Amyloid Precursor Protein
Westmark, C. J., & Malter, J. S. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050052 · Cited by 292 · see citing works
“when mature connections are completed [48,49].”
Sabo, S. L., Ikin, A. F., Buxbaum, J. D., & Greengard, P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05407.2003 · Cited by 187 · see citing works
Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions
Elmaleh, D. R., Farlow, M. R., Conti, P. S., Tompkins, R. G., Kundakovic, L., & Tanzi, R. E. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190507 · Cited by 129 · see citing works
Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
Westmark, C. J., Westmark, P. R., O'Riordan, K. J., Ray, B. C., Hervey, C. M., Salamat, M. S., Abozeid, S. H., Stein, K. M., Stodola, L. A., Tranfaglia, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026549 · Cited by 110 · see citing works
Ikin, A. F., Sabo, S. L., Lanier, L. M., & Buxbaum, J. D. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.003 · Cited by 38 · see citing works
- Authors
- Moya, K. L., Benowitz, L. I., Schneider, G. E., & Allinquant, B.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Developmental Biology
- Publisher
- Elsevier BV
- Published
- 1994-02
- Volume
- 161
- Issue
- 2
- Pages
- 597-603
- ISSN
- 0012-1606 (ISSN-L)
- OpenAlex
- W2070232448
- Cited by
- 157
- References
- 0
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 5 · 2018: 1 · 2017: 2 · 2016: 6 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 8
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Developmental Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY005690, EY00126, EY05690)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- amyloid precursor protein, synaptogenesis, axon elongation, developmental regulation, visual pathway, neuronal differentiation, cell adhesion, APP cleavage, synaptic connectivity, hamster, Alzheimer's disease
- MeSH terms
- Age Factors, Animals, Axons, Cricetinae, Mesocricetus, Molecular Weight, Synapses, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review